Mahmoud Nazih, PhD
PhD in Clinical Pharmacy · BCPS
Lecturer of Clinical Pharmacology, Al-Ryada University for Science and Technology
I am a clinical pharmacist and researcher with over a decade of inpatient practice across tertiary-care, specialized, and academic hospitals. My research focuses on clinical pharmacogenomics, especially in oncology, and on using a patient's genes and biomarkers to choose and dose their therapy.
- Pharmacogenomics
- Oncology Pharmacotherapy
- Hepatocellular Carcinoma
- Antimicrobial Stewardship
- Precision Medicine
+16 Peer-reviewed publications
+13 In Q1 journals
+10 Years of clinical practice
BCPS Board certified (BPS, USA)
Selected Publications
Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC): A LncRNA-Expression Guided Approach Using UCA1 and MALAT1 for Personalizing Therapy in a 154-Patient Cohort Pharmaceuticals · 2025Q1
Real-world outcomes and predictive factors in hepatocellular carcinoma patients treated with sorafenib: an 18-month ambispective cohort analysis Future Journal of Pharmaceutical Sciences · 2025Q2
FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and Survival International Journal of Molecular Sciences · 2025Q1
Therapeutic potential of brentuximab vedotin in breast cancer and lymphoma via targeted apoptosis and gene regulation Scientific Reports · 2025Q1
Talks & Highlights
Keynote Speaker Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC) April 2026
PhD Candidate Clinical Study of the Efficacy and Safety of Sorafenib in Egyptian Patients with Hepatocellular Carcinoma 2026
Speaker Invited Talk 29 September 2024
Speaker (Part 2) The Convergence of Pharmacogenomics and Immunology: From Bench to Bedside in the Era of Precision Medicine 5 July 2023